Instil Bio, Inc.
TIL
$7.93
-$0.05-0.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 48.68% | 39.71% | 36.49% | 24.13% | -137.07% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | -97.59% | -32.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 59.79% | -57.18% | -80.44% | -41.48% | 325.96% |
| Change in Net Operating Assets | 913.28% | -82.73% | 114.68% | -239.49% | 188.83% |
| Cash from Operations | 81.11% | 32.97% | 28.63% | -252.59% | 60.27% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 80.00% | -61.54% | -96.79% | 26.56% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -104.06% | -7.50% | 2,144.07% | -104.49% | -27.40% |
| Cash from Investing | -104.05% | -7.45% | 2,211.75% | -104.16% | -26.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -94.59% | 1,628.22% | 96.12% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -74.42% | 87.46% |
| Cash from Financing | -- | -100.00% | -94.34% | 2,780.17% | -85.46% |
| Foreign Exchange rate Adjustments | 73.68% | 24.00% | -219.05% | -51.16% | 166.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -329.46% | 141.15% | 79.30% | -249.15% | 43.28% |